UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$566.03 USD
-5.31 (-0.93%)
Updated Oct 17, 2024 04:00 PM ET
Pre-Market: $563.30 -2.73 (-0.48%) 9:26 AM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$566.03 USD
-5.31 (-0.93%)
Updated Oct 17, 2024 04:00 PM ET
Pre-Market: $563.30 -2.73 (-0.48%) 9:26 AM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Zacks News
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $244.70 in the latest trading session, marking a +0.44% move from the prior day.
Zacks Value Trader Highlights: PayPal, Abbott Labs, UnitedHealth, Lam Research and Visa
by Zacks Equity Research
Zacks Value Trader Highlights: PayPal, Abbott Labs, UnitedHealth, Lam Research and Visa
Why Does the Stock of Cigna (CI) Look Attractive Now?
by Zacks Equity Research
The acquisition of Express Scripts by Cigna (CI) presents another major growth point for the company.
These 5 Companies are Earnings Perfection
by Tracey Ryniec
Looking for only the best this earnings season? These companies haven't missed on earnings in the last 5 years.
Dow Posts Longest Winning Run Since November: 5 Top Picks
by Nalak Das
The Dow - commenced 2019 on a brighter note. Positive developments on trade war front and Fed???s monetary stance are likely to boost investor sentiment in the near-term resulting in further consolidation of the index.
UnitedHealth Group (UNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $239.62, marking a +1.17% move from the previous day.
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
Top Analyst Reports for UnitedHealth, CVS Health & General Electric
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), CVS Health (CVS) and General Electric (GE).
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $246.24 in the latest trading session, marking a +0.11% move from the prior day.
5 Worst Performing Stocks of Dow ETF Last Week
by Sweta Killa
Dow Jones suffered its worst week since the global financial crisis of 2008. We have highlighted five worst-performing stocks in the ETF.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $252.97, moving -1.98% from the previous trading session.
Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?
by Sweta Killa
Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.
Will Lower Revenues Hurt BlackBerry's (BB) Q3 Earnings?
by Zacks Equity Research
BlackBerry (BB) is likely to report lower year-over-year revenues in the fiscal third quarter, primarily due to negative impact of the changes in the accounting and sales model.
Healthcare Battered By Texas ACA Ruling
by Zacks Equity Research
Healthcare Battered By Texas ACA Ruling
Healthcare Stocks Take a Hit on Texas ACA Ruling
by Mark Vickery
Throwing out ACA as healthcare law in the U.S. would create plenty of tremors within the healthcare industry -- to say nothing of Insurance, Pharmaceuticals and related business sectors.
Why the Earnings Surprise Streak Could Continue for UnitedHealth (UNH)
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $270.64, marking a +1.28% move from the previous day.
The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle
Top Analyst Reports for UnitedHealth, Broadcom & CVS Health
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Broadcom (AVGO) and CVS Health (CVS).
Has UnitedHealth Group (UNH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?
A Tough Start to December as Stocks Slide Again
by David Borun
China, Brexit and generally uncertainty contribute to another decline in US equities
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $276.85, marking a -0.61% move from the previous day.
WellCare (WCG) Buys Aetna's Medicare Assets to Fuel Growth
by Zacks Equity Research
WellCare's (WCG) purchase of Medicare business of Aetna should lead to long-term growth.